CHRNA7 and schizophrenia: In addition to α2C AR, the α7 nicotinic acetylcholine receptor (nAChR) has been considered as one of the most promising schizophrenia drug targets, this being partly attributable to the evidence of dysfunctional nAChRs in schizophrenia (for a review, see Wallace and Bertrand 2015).